The Eye Centers of Racine and Kenosha   Report issue

Academic/Hospital Phase 4
Founded: Racine WI United States (1981)

Organization Overview

First Clinical Trial
2019
NCT04237012
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Eye Centers of Racine and Kenosha

Active Ingredients

Drugs in Phase 4 Trials (1)

dexamethasone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1